Cargando…
Antisense therapeutics in oncology: current status
There is increasing progress in translational oncology and tremendous breakthroughs have been made as evidenced by preclinical and clinical trials. Data obtained from high-throughput technologies are deepening our understanding about the molecular and gene network in cancer cells and rapidly emergin...
Autores principales: | Farooqi, Ammad Ahmad, Rehman, Zia ur, Muntane, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224095/ https://www.ncbi.nlm.nih.gov/pubmed/25395862 http://dx.doi.org/10.2147/OTT.S49652 |
Ejemplares similares
-
Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology
por: Naoum, George E., et al.
Publicado: (2017) -
Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015) -
Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2018) -
MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2017) -
Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers of ‘the dance macabre’
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2012)